Bushra Shahida

Telefon+46760833883
E-postadressbushra.shahidamed.luse
Webbplatshttp://www.ludc.med.lu.se/diabendo/

Om du gjort några ändringar i Pure kommer de visas här snart.

Forskning

Forskningsområde: Orsaker, riskfaktorer, behandling vid endokrin oftalmopati.

Ämnesklassifikation (UKÄ)

Cell- och molekylärbiologi
Medicin och hälsovetenskap
Medicinsk genetik
Immunologi inom det medicinska området

Fingeravtryck

Utforska forskningsämnen där Bushra Shahida är aktiv. Dessa ämnesetiketter kommer från personens arbeten. Tillsammans bildar de ett unikt fingeravtryck.

1 Liknande profiler

10 Artikel i vetenskaplig tidskrift
1 Doktorsavhandling (sammanläggning)

Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
Shahida, B., Tsoumani, K., Planck, T., Modhukur, V., Asp, P., Sundlöv, A., Tennvall, J., Åsman, P., Lindgren, O. & Lantz, M., 2021, (E-pub ahead of print) I: Endocrine.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Molecular Mechanisms of Graves' Ophthalmopathy. A focus on smoking and radioiodine.
Shahida, B., 2021, Lund: Lund University, Faculty of Medicine. 109 s.
Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Öppen tillgång
Fil
109 Nedladdningar (Pure)
Serum CYR61 Levels are Associated with Graves' Ophthalmopathy and Smoking in Patients with Graves' Disease
Cerri, P., Shahida, B., Lantz, M. & Planck, T., 2021 mars 1, I: Hormone and Metabolic Research. 54, 3, s. 168-174 7 s.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus
Shaat, N., Katsarou, A., Shahida, B., Prasad, R. B., Kristensen, K. & Planck, T., 2020, I: PLoS ONE. 15, 5, e0232297.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
4 Citeringar (SciVal)
Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients
Shahida, B., Johnson, P. S., Jain, R., Brorson, H., Åsman, P., Lantz, M. & Planck, T., 2019, I: Endocrine Connections. 8, 9, s. 1230-1239 10 s.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
9 Citeringar (SciVal)

Bushra Shahida

Personlig profil

Forskning

Ämnesklassifikation (UKÄ)

Fingeravtryck

Nätverk

Se detaljer

Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres

Molecular Mechanisms of Graves' Ophthalmopathy. A focus on smoking and radioiodine.

Serum CYR61 Levels are Associated with Graves' Ophthalmopathy and Smoking in Patients with Graves' Disease

Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus

Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients

Bushra Shahida

Personlig profil

Forskning

Ämnesklassifikation (UKÄ)

Fingeravtryck

Nätverk

Forskningsoutput

Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres

Molecular Mechanisms of Graves' Ophthalmopathy. A focus on smoking and radioiodine.

Serum CYR61 Levels are Associated with Graves' Ophthalmopathy and Smoking in Patients with Graves' Disease

Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus

Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients